Vitamin A (Capsules) Instructions for Use
ATC Code
A11CA01 (Retinol (vitamin A))
Active Substance
Retinol (Rec.INN registered by WHO)
Clinical-Pharmacological Group
Vitamin preparation
Pharmacotherapeutic Group
Vitamins; vitamins A and D, including their combinations; vitamin A
Pharmacological Action
Vitamin A is a fat-soluble vitamin. It has a diverse effect on the body’s vital activities.
It plays an important role in redox processes (due to a large number of unsaturated bonds), participates in the synthesis of mucopolysaccharides, proteins, and lipids. Retinol plays an important role in maintaining the normal condition of the skin and epithelium of mucous membranes, ensuring normal differentiation of epithelial tissue, and in the processes of photoreception (promotes human adaptation to darkness).
Retinol participates in mineral metabolism, cholesterol formation processes, enhances the production of lipase and trypsin, enhances myelopoiesis, and cell division processes. The local action is mediated by the presence of specific retinol-binding receptors on the surface of epithelial cells.
It inhibits keratinization processes, enhances the proliferation of epithelial cells, rejuvenates cell populations, and reduces the number of cells that follow the path of terminal differentiation.
It is believed that Retinol has an antitumor effect, which, however, does not extend to non-epithelial tumors.
Indications
Hypovitaminosis and avitaminosis A. Eye diseases (pigmentary retinitis, nyctalopia, xerophthalmia, keratomalacia, eczematous lesions of the eyelids), skin diseases and lesions (frostbite, burns, wounds, ichthyosis, hyperkeratosis, psoriasis, some forms of eczema and other inflammatory and degenerative pathological processes).
Complex therapy of rickets, hypotrophy, acute respiratory infections, chronic bronchopulmonary diseases, erosive-ulcerative and inflammatory lesions of the gastrointestinal tract, liver cirrhosis.
Epithelial tumors and leukemias (to increase the resistance of hematopoietic tissue to the action of cytostatics during complex chemotherapy). Mastopathy (as part of a complex of non-hormonal agents).
ICD codes
| ICD-10 code | Indication |
| C80 | Malignant neoplasm without specification of site |
| C95.9 | Leukemia, unspecified |
| E46 | Unspecified protein-energy malnutrition |
| E50 | Vitamin A deficiency |
| E55.0 | Active rickets |
| H01.1 | Noninfectious dermatoses of eyelid |
| H04.1 | Other disorders of lacrimal gland (dry eye syndrome) |
| H18.0 | Corneal pigmentations and deposits |
| H18.4 | Corneal degeneration |
| H35.5 | Hereditary retinal dystrophies |
| H53.1 | Subjective visual disturbances |
| J06.9 | Acute upper respiratory infection, unspecified |
| J42 | Unspecified chronic bronchitis |
| J44 | Other chronic obstructive pulmonary disease |
| K25 | Gastric ulcer |
| K26 | Duodenal ulcer |
| K27 | Peptic ulcer |
| K29 | Gastritis and duodenitis |
| K52.9 | Noninfective gastroenteritis and colitis, unspecified |
| K74 | Fibrosis and cirrhosis of liver |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L30.0 | Nummular eczema |
| L30.9 | Dermatitis, unspecified |
| L40 | Psoriasis |
| L85.0 | Acquired ichthyosis |
| L85.1 | Acquired keratosis [keratoderma] palmaris et plantaris |
| L85.2 | Punctate keratosis (palmar-plantar) |
| N60 | Benign mammary dysplasia (including fibrocystic mastopathy) |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| T33 | Superficial frostbite |
| ICD-11 code | Indication |
| 2B33.4 | Leukemia, unspecified |
| 2D4Z | Unspecified malignant neoplasms of ill-defined or unspecified sites |
| 5B50 | Deficiency of weight in infants, children and adolescents |
| 5B51 | Exhaustion in infants, children and adolescents |
| 5B52 | Acute protein-energy malnutrition in infants, children and adolescents |
| 5B53 | Growth delay in infants, children and adolescents |
| 5B54 | Underweight in adults |
| 5B55.Z | Vitamin A deficiency, unspecified |
| 5B57.0 | Vitamin D-dependent rickets |
| 5B71 | Protein deficiency |
| 9A06 | Certain specified disorders of the eyelids |
| 9A06.70 | Atopic eczema of the eyelids |
| 9A1Z | Diseases of the lacrimal system, unspecified |
| 9A78.1 | Corneal pigmentation or deposits |
| 9A78.4 | Corneal degeneration |
| 9B70 | Hereditary retinal dystrophies |
| 9D51 | Transient vision loss |
| 9D5Z | Subjective visual disturbances, unspecified |
| 9E1Y | Other specified diseases of the visual system |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA22.Z | Chronic obstructive pulmonary disease, unspecified |
| DA42.Z | Gastritis, unspecified |
| DA51.Z | Duodenitis, unspecified |
| DA60.Z | Gastric ulcer, unspecified |
| DA61 | Peptic ulcer of unspecified site |
| DA63.Z | Duodenal ulcer, unspecified |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DA90.0 | Syndromic diarrhea |
| DB93 | Fibrosis or cirrhosis of liver |
| DE2Z | Diseases of the digestive system, unspecified |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EA90.Z | Psoriasis, unspecified |
| EC20.32 | Papular palmoplantar keratodermas |
| ED50.0 | Acquired ichthyosis |
| ED55.0 | Acquired palmoplantar keratodermas |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| GB20.Z | Benign breast disease, unspecified |
| ND56.0 | Superficial injury of unspecified body region |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| NE40 | Superficial frostbite |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take capsules orally with a meal to enhance absorption.
For severe vitamin A deficiency in adults, administer up to 100,000 IU daily for 3 days, followed by 50,000 IU daily for 2 weeks.
For maintenance therapy in adults, use 10,000 to 20,000 IU daily for 2 months.
For skin diseases like psoriasis or eczema, prescribe 100,000 to 300,000 IU daily.
For pediatric patients over 7 years old, administer 1,000 to 5,000 IU daily based on body weight and severity of deficiency.
Adjust the daily dosage and treatment duration individually according to clinical response and serum retinol levels.
Limit the treatment course to avoid hypervitaminosis; do not exceed 6,000 IU/kg body weight.
For prophylactic use in populations at risk, a single dose of 200,000 IU is acceptable.
In cases of malabsorption, consider a higher dosage or parenteral administration under strict medical supervision.
Monitor patients for signs of toxicity, especially with long-term use exceeding 4,000 IU daily.
Adverse Reactions
Hypervitaminosis A in adults – drowsiness, lethargy, headache, facial flushing, nausea, vomiting, gait disturbances, pain in the bones of the lower extremities; in children, fever, drowsiness, sweating, vomiting, skin rashes are possible.
Possible increase in cerebrospinal fluid pressure (in infants, hydrocephalus and bulging of the fontanelle may develop).
Contraindications
Cholelithiasis, chronic pancreatitis (exacerbation of the disease is possible), acute inflammatory skin diseases, pregnancy, breastfeeding period, children under 7 years of age.
With caution
Nephritis, heart failure of II-III degree, chronic alcoholism, liver cirrhosis, viral hepatitis, renal failure.
Use in Pregnancy and Lactation
Use is contraindicated during pregnancy and breastfeeding.
Use in Hepatic Impairment
Use is contraindicated in cholelithiasis.
With caution: liver cirrhosis, viral hepatitis.
Use in Renal Impairment
Use with caution in acute and chronic nephritis, renal failure.
Pediatric Use
Use is contraindicated in children under 7 years of age.
Geriatric Use
Use with caution in elderly patients.
Special Precautions
Use with caution in acute and chronic nephritis, in decompensation of cardiac activity.
No more than one preparation containing Retinol should be used simultaneously to avoid overdose.
Drug Interactions
With simultaneous use with cholestyramine, colestipol, neomycin, a decrease in the absorption of retinol is possible.
During long-term therapy with tetracyclines, vitamin A is not recommended to be prescribed due to the risk of intracranial hypertension.
Oral contraceptives increase the plasma concentration of retinol.
Isotretinoin increases the risk of adverse effects.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Capsules 33,000 IU
Marketing Authorization Holder
Meligen FP, CJS (Russia)
Dosage Form
| Vitamin A | Capsules 33,000 IU |
Dosage Form, Packaging, and Composition
Capsules
| 1 caps. | |
| Retinol palmitate (Vitamin A) calculated as 100% vitamin A | 18.2 mg (33000 IU) |
10 pcs. – blister packs – cardboard packs (10 pcs.) – Over-the-Counter
10 pcs. – blister packs (10 pcs.) – cardboard packs (100 pcs.) – Over-the-Counter
10 pcs. – blister packs (100 pcs.) – cardboard boxes (1000 pcs.) – for hospitals
10 pcs. – blister packs (100 pcs.) – polyethylene bags (1000 pcs.) – for hospitals
10 pcs. – blister packs (1000 pcs.) – cardboard boxes (10000 pcs.) – for hospitals
10 pcs. – blister packs (2 pcs.) – cardboard packs (20 pcs.) – Over-the-Counter
10 pcs. – blister packs (200 pcs.) – cardboard boxes (2000 pcs.) – for hospitals
10 pcs. – blister packs (200 pcs.) – polyethylene bags (2000 pcs.) – for hospitals
10 pcs. – blister packs (2000 pcs.) – cardboard boxes (20000 pcs.) – for hospitals
10 pcs. – blister packs (3 pcs.) – cardboard packs (30 pcs.) – Over-the-Counter
10 pcs. – blister packs (4 pcs.) – cardboard packs (40 pcs.) – Over-the-Counter
10 pcs. – blister packs (400 pcs.) – cardboard boxes (4000 pcs.) – for hospitals
10 pcs. – blister packs (400 pcs.) – polyethylene bags (4000 pcs.) – for hospitals
10 pcs. – blister packs (4000 pcs.) – cardboard boxes (40000 pcs.) – for hospitals
10 pcs. – blister packs (50 pcs.) – cardboard boxes (500 pcs.) – for hospitals
10 pcs. – blister packs (50 pcs.) – polyethylene bags (500 pcs.) – for hospitals
10 pcs. – blister packs (6 pcs.) – cardboard packs (60 pcs.) – Over-the-Counter
10 pcs. – blister packs (600 pcs.) – cardboard boxes (6000 pcs.) – for hospitals
10 pcs. – blister packs (600 pcs.) – polyethylene bags (6000 pcs.) – for hospitals
10 pcs. – blister packs (6000 pcs.) – cardboard boxes (60000 pcs.) – for hospitals
Capsules 33 thousand IU: 10, 20, 30, 40, 100, 500, 1000, 2000, 4000, 6000 pcs.
Marketing Authorization Holder
Meligen FP, CJS (Russia)
Dosage Form
| Vitamin A (Retinol acetate) | Capsules 33 thousand IU: 10, 20, 30, 40, 100, 500, 1000, 2000, 4000, 6000 pcs. |
Dosage Form, Packaging, and Composition
Capsules from light yellow to dark yellow, soft, gelatinous, spherical in shape; filled with an oily liquid from light yellow to dark yellow, without a rancid odor.
| 1 caps. | |
| Retinol acetate (calculated as 100% vitamin A) | 33000 IU (11.35 mg) |
Excipients : soybean oil up to 150 mg.
Capsule shell gelatin 31.04 mg, glycerol 9.76 mg, methylparahydroxybenzoate 0.2 mg
10 pcs. – blister packs.
10 pcs. – blister packs (2) – cardboard packs.
10 pcs. – blister packs (3) – cardboard packs.
10 pcs. – blister packs (4) – cardboard packs.
10 pcs. – blister packs (10) – cardboard packs.
10 pcs. – blister packs (50) – cardboard boxes.
10 pcs. – blister packs (100) – cardboard boxes.
10 pcs. – blister packs (200) – cardboard boxes.
10 pcs. – blister packs (400) – cardboard boxes.
10 pcs. – blister packs (600) – cardboard boxes.
Belosalic, lotion solution for external use spray 100ml
No-spa pills 40mg, 64pcs
Arbidol, capsules 100mg, 40pcs
Noopept, pills 10mg, 50pcs
Fenotropil pills 100mg, 60pcs
Kagocel pills 12mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Mildronate capsules 500mg, 90pcs
Nootropil pills 800mg, 30pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Picamilon pills 50mg, 60pcs
Phenibut-Vertex pills 250mg, 20pcs
Cortexin, 10mg, 5ml, 10pcs 